Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Eisai’s Bose to join Boehringer

He becomes head of global marketing for oncology

- PMLiVE

Sun Pharma recalls antidepressant in US

Withdraws more than 40,000 bottles of venlafaxine hydrochloride

dengue fever mosquito

Sanofi’s dengue vaccine could debut in 2015

End in sight after 20-year wait for first effective vaccine

EU flag

EMA transparency policy delayed over ‘wording’

Regulation on access to trial data postponed until October

Samsung incentivises African mHealth project with music

Will also offer discounted handsets and tablets to consumers and health workers

UK flag

Cipla invests £100m in UK

Indian pharma company to fund both commercial and R&D activities

- PMLiVE

Pharma’s shrinking waterhole

A natural metaphor makes us think about our strategy

- PMLiVE

UDG buys Galliard and Nyxeon

Will add UK comms firms to Ashfield Healthcare Communications division

Baxter reshuffles financial heads

Names CFOs for biotech spin-off and 'new' Baxter

- PMLiVE

Illumina to provide sequencing for UK gene project

Genomics England wants company to sequence genomes of 100,000 NHS patients

- PMLiVE

EU hits Servier and generic firms with €428m ‘pay-for-delay’ fine

Follows deals to delay competition for blood pressure drug Coversyl/Aceon

Novartis building

Novartis’ secukinumab tops Enbrel in psoriasis

Data reinforces secukinumab's position among new generation of biologic

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links